Table 1 Patient and tumor characteristics
Variables | No. of patients (%) |
|---|---|
Age (years) | |
Median | 65 |
Range | 30–82 |
ECOG performance score | |
0 | 6 (12.0) |
1 | 34 (68.0) |
2 | 10 (20.0) |
Timing of SABR | |
Synchronous | 11 (22.0) |
1st recurrence | 22 (44.0) |
2nd recurrence | 14 (28.0) |
3rd recurrence | 3 (6.0) |
Previous Chemotherapy before SABR | |
Yes | 32 (64.0) |
No | 18 (36.0) |
Reason for SABR | |
Inoperable | 32 (64.0) |
Other | 18 (36.0) |
GTV (mL) | |
Median | 1.5 |
Range | 0.2–34.8 |
Prescription dose | |
40 Gy / 4 fx | 1 (1.3) |
48 Gy / 4 fx | 55 (69.6) |
60 Gy / 4 fx | 20 (25.3) |
60 Gy / 3 fx | 3 (3.8) |